A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

Summary

This study will compare LY900014, a drug that lowers blood sugar, with insulin lispro (Humalog). Both drugs will be given by injection under the skin of the abdomen. This study will be conducted in participants with type 1 diabetes to investigate how quickly and how much LY900014 is absorbed and the effect of LY900014 on blood sugar levels in comparison with insulin lispro. The study will last about 3 to 6 weeks for each participant, not including screening.

Timeline

Start

2018-02-17

Primary completion

2018-06-23

Completion

2018-07-12

Drugs

Indications